Longevity Direct logo in color – promoting personalized longevity insights and AI-driven health optimization
get Started

LDL Particle Size

LDL Particle Number

ANA (Antinuclear Antibody)

Lipoprotein(a) [Lp(a)]

Platelet Count

Bilirubin (Total and Direct)

Phosphorous

DHA (Docosahexaenoic Acid)

Calcium

MCV (Mean Corpuscular Volume)

SHBG (Sex Hormone Binding Globulin)

Creatinine

Lymphocytes (Absolute)

Bicarbonate

Sed Rate (Erythrocyte Sedimentation Rate)

Serum Iron

MCHC (Mean Corpuscular Hemoglobin Concentration)

Basophils (Absolute)

BUN (Blood Urea Nitrogen)

ALT (Alanine Aminotransferase)

Cystatin C

GGT (Gamma-Glutamyl Transferase)

HDL Cholesterol

Fibrinogen

Hematocrit

Reverse T3 (rT3)

RBC (Red Blood Cell Count)

Free Testosterone

TNF-α (Tumor Necrosis Factor-alpha)

LDH (Lactate Dehydrogenase)

Total Protein

Monocytes (Absolute)

AST (Aspartate Aminotransferase)

Homocysteine

ApoA/ApoB Ratio

TIBC (Total Iron Binding Capacity)

BUN/Creatinine Ratio

Hemoglobin

Ferritin

Neutrophils (Absolute)
HOMA-IR is a valuable biomarker for assessing insulin resistance, an important factor in longevity and age-related health. Understanding and monitoring HOMA-IR levels can provide insight into the risk of chronic diseases and overall lifespan.

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance)

HOMA-IR is a valuable biomarker used in longevity research to assess insulin resistance, a key factor in aging and age-related diseases. As a measure of the body’s ability to maintain glucose homeostasis, HOMA-IR provides insight into metabolic health and overall risk of chronic conditions such as diabetes, cardiovascular disease, and cancer. Lower HOMA-IR levels are associated with improved cellular function and longevity, making it an important tool for identifying individuals at higher risk for age-related health issues. By monitoring and optimizing HOMA-IR, researchers and healthcare professionals can better understand and promote healthy aging.

Biomarker Explained

Insulin resistance is a key factor in aging and age-related diseases, and HOMA-IR is a valuable biomarker used in longevity research to assess it. By measuring the body’s ability to maintain glucose homeostasis, HOMA-IR provides insight into metabolic health and overall risk of chronic conditions such as diabetes, cardiovascular disease, and cancer. Lower HOMA-IR levels are associated with improved cellular function and longevity, making it an important tool for identifying individuals at higher risk for age-related health issues. Monitoring and optimizing HOMA-IR can help researchers and healthcare professionals better understand and promote healthy aging by identifying and addressing potential risk factors.

Keywords:

Insulin resistance, HOMA-IR, aging, longevity, biomarker, glucose homeostasis, chronic conditions

Your Longevity Clinic,
from Home.

Longevity Direct is an app within Longr’s Longevity OS, a platform dedicated to extending access to longevity. 

Verify Approval for www.longevity.direct

Home

Rapamycin

Metformin

GLP-1

General Longevity
Heart Health
Weight Management
Glucose Control
Cognitive Function
Diabetes Prevention
Mood Support
Energy & Fatigue
Autoimmune Support
Blood Pressure
Chronic Pain & Arthritis
Aging Skin
Men’s Aging
Women’s Aging

Longevity Library
About

Contact

Client portal

© 2025 Longr Holdings Inc.
1007 North Orange Street | DE 19801 | U.S.A

Prescription products require an online consultation with a physician who will determine if a prescription is appropriate. See product page for important safety information. Benefits outlined on Longevity Direct are based on 3rd party studies.

Note: The above statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. If you are in need of emergency medical attention, please call 911 immediately.

Longevity Direct logo in color – promoting personalized longevity insights and AI-driven health optimization

Rapamycin

Metformin

GLP-1

General Longevity
Heart Health
Weight Management
Glucose Control
Cognitive Function
Diabetes Prevention
Mood Support
Energy & Fatigue
Autoimmune Support
Blood Pressure
Chronic Pain & Arthritis
Aging Skin
Men’s Aging
Women’s Aging

Longevity Library
About

get Started
Client portal

Contact

Questions, suggestions, reflections?

Fill out the form below and a member of our team well get back to you as soon as possible.

FAQS
Contact Form (#14)

How does Rapaymcin work?

Rapamycin slows aging by targeting the mTOR pathway, shifting the body’s focus from growth to repair. It promotes cellular recycling, reduces overgrowth linked to disease, and enhances resilience to stress.

Imagine your body as a city, bustling with activity.

Cells are the workers, and mTOR (mechanistic target of rapamycin) is the city planner, deciding where to focus resources – building new structures, cleaning up waste, or repairing old ones.

As we age, mTOR often prioritizes building (cell growth) over maintenance (cellular repair), leading to “clutter” in our bodies that contributes to aging and disease.

This is where Rapamycin comes in.

It acts like a wise advisor to mTOR, convincing it to slow down unnecessary growth projects and focus on clean up and repair instead.

Specifically, Rapamycin:

Activates cellular recycling (autophagy):

Think of autophagy as the city’s waste management system. Damaged parts of cells are broken down and reused, keeping the system efficient and healthy.

Reduces harmful overgrowth:

Overactive mTOR has been linked to diseases such as cancer, cardiovascular disease, and neurodegenerative conditions like Alzheimer’s. By dialing back excessive growth signals, Rapamycin helps prevent these issues.

Supports stress resilience:

When cells are less focused on growing, they’re better equipped to handle stress, repair damage, and maintain long-term health.